Precision Business Insights
Portfolio

 

Global Peptide API CMO Market

: Global Market Estimation, Dynamics, Trends, Competitor Analysis 2014-2018 and Forecast 2019-2025

Global Peptide API CMO Market: By Product Type (Peptide Generic API, Peptide NCEs), By Therapeutic area (Oncology, Cardiovascular Disorders, metabolic Disorders, CNS Disorders, Respiratory Disorders, Gastrointestinal Disorders, Anti-infective, Dermatology, Renal Disorders, Others), End User (Pharmaceutical Companies, Biopharmaceutical Companies) and Geography

 

Global Peptide API CMO Market

 

Global Peptide API CMO Market Report Description:

Global peptide API CMO market report gives comprehensive outlook on peptide API CMO across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The report on global peptide API CMO market gives historical, current, and future market sizes (US$ Mn) on the basis of product type, therapeutic area, end user, and region. This report studies global market dynamics elaborately to indentify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, global market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global peptide API CMO market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the global peptide API CMO market report include suppliers, manufacturers, marketers, policy makers, and healthcare service providers engaged in global peptide API CMO products.

 

Peptide API CMO Market:

Global Market estimated to be valued US$ XX Mn in 2018 and poised to grow at significant CAGR over 2019-2025 due to increase in prevalence of various types of cancers, other chronic disorders. Moreover, rise in number of deaths due to diseases which do not possess complete cure with the conventional drugs, increasing demand for the R&D services by public and private sectors, increasing global geriatric population, and wide range of applications with the peptide API CMO are the major factors that are driving the growth of the global peptide API CMO market over the forecast timeframe.

 

Increase in the Prevalence of Cancer   

Increase in the prevalence of cancer, autoimmune disorders, and other chronic diseases is a key factor drive the global peptide API CMO market. According to World Health Organization 2018, approximately 9.6 Mn death occurred due to cancer around the globe. Moreover, product approval by the FDA for protein and peptide APIs, raise in funding for the R&D activities by public and private sectors are anticipated to propel the global peptide API CMO market over the forecast years.

 

North America Accounts for Larger Market Revenue Share in Global Peptide API CMO Market

North America accounted for larger revenue share in global peptide API CMO market with significant CAGR. Increase in prevalence of cancer and other chronic life threatening diseases, rise in R&D activities for the development of peptide API, increased demand for the contract manufacturing organizations which work on the development of protein and peptide APIs  and rise in awareness about the peptide API among the healthcare professionals in U.S. and Canada are anticipated to propel the market. Asia Pacific peptide API CMO market projected to grow at significant rate owing to increase in research and development on new protein and peptide based products in the market, favorable reimbursement policies, easy availability of raw material, increasing number of CMOs and increase in healthcare expenditure are expected to enhance the market.

 

Competition Assessment

 

  • ScinoPharm Taiwan, Ltd. (Taiwan)
  • Corden Pharma International (Germany)
  • Bachem AG (Switzerland)
  • Biopeptek Pharmaceuticals LLC. (U.S.)
  • Hybio Pharmaceutical Co., Ltd. (China)
  • Chinese Peptide Company (China)
  • AmbioPharm, Inc. (U.S.)
  • Teva Pharmaceutical Industries Ltd. (Israel)
  • PolyPeptide Group (Sweden)
  • Chemi S.p.A. (Italy)

 

Key Findings of the Report:

 

  • Global market expanding at significant CAGR over 2019 to 2025 owing to increase in the prevalence of cancer and other infectious diseases
  • Based on product type, peptide generic API segment accounted for larger market revenue share in 2018 and projected gain market revenue share over the forecast period
  • Players focusing on innovation of newer products and collaboration strategies to retain market position in global peptide API CMO market

 

Detailed Segmentation

 

By Product Type

  • Peptide Generic API
  • Peptide NCEs

 By Therapeutic area

  • Oncology
  • Cardiovascular Disorders
  • metabolic Disorders
  • CNS Disorders
  • Respiratory Disorders
  • Gastrointestinal Disorders
  • Anti-infective
  • Dermatology
  • Renal Disorders
  • Others

End User

  • Pharmaceutical Companies
  • Biopharmaceutical Companies

Geography

 

North America

  • US
  • Canada

Europe

  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Russia
  • Poland
  • Rest of Europe

Asia-Pacific

  • Japan
  • China
  • India
  • Australia & New Zealand
  • ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
  • South Korea
  • Rest of Asia-Pacific

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Venezuela
  • Rest of Latin America

Middle East and Africa (MEA)

  • Gulf Cooperation Council (GCC) Countries
  • Israel
  • South Africa
  • Rest of MEA

 

Key Features of the Report:

 

  • The report provides granular level information about the market size, regional market share, historic market (2014-2018) and forecast (2019-2025)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

 

Table of Content

  1. Executive Summary
  2. Global Peptide API CMO Market Introduction
    • Global Peptide API CMO Market – Taxonomy
    • Global Peptide API CMO Market –Definitions
      • Product Type
      • Therapeutic Area
      • End User
  1. Global Peptide API CMO Market Dynamics
    • Drivers
    • Restraints
    • Opportunities/Unmet Needs of the Market
    • Trends
    • Global Peptide API CMO Market Dynamic Factors – Impact Analysis
    • Global Peptide API CMO Market – Competition Landscape
  2. Global Peptide API CMO Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025
    • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
    • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Market Opportunity Analysis
  3. Global Peptide API CMO Market, By Product Type, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
    • Peptide Generic API
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Peptide NCEs
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Peptide API CMO Market Forecast, By Therapeutic Area, 2014 – 2018 and Forecast, 2019 – 2025
    • Oncology
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Cardiovascular Disorders
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Metabolic Disorders
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • CNS Disorders
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Respiratory Disorders
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Gastrointestinal Disorders
        • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Anti-infective Drugs
        • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Dermatology
        • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
          • Market Opportunity Analysis
        • Renal Disorders
          • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
          • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
          • Market Opportunity Analysis
        • Others
          • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
          • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            • Market Opportunity Analysis
  1. Global Peptide API CMO Market Forecast, By End User, 2014 – 2018 and Forecast, 2019 – 2025
    • Pharmaceutical Companies
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Biopharmaceutical Companies
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Peptide API CMO Market Forecast, By Region, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
    • North America
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Europe
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Asia-Pacific
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Latin America
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Middle East and Africa
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Global Peptide API CMO Market – Opportunity Analysis Index, By Product Type, Therapeutic Area, End User, and Region, 2019 – 2025
  2. North America Peptide API CMO Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
    • By Product Type Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Peptide Generic API
      • Peptide NCEs
    • Therapeutic Area Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Oncology
      • Cardiovascular Disorders
      • metabolic Disorders
      • CNS Disorders
      • Respiratory Disorders
      • Gastrointestinal Disorders
      • Anti-infectives
      • Dermatology
      • Renal Disorders
      • Others 
    • End User Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Pharmaceutical Companies
      • Biopharmaceutical Companies
    • Country Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • US.
      • Canada
    • North America Peptide API CMO Market – Opportunity Analysis Index, By Product Type, Therapeutic Area, End User, and Country, 2019 – 2025
    • North America Peptide API CMO Market Dynamics – Trends
  3. Europe Peptide API CMO Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
    • By Product Type Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Peptide Generic API
      • Peptide NCEs
    • Therapeutic Area Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Oncology
      • Cardiovascular Disorders
      • metabolic Disorders
      • CNS Disorders
      • Respiratory Disorders
      • Gastrointestinal Disorders
      • Anti-infectives
      • Dermatology
      • Renal Disorders
      • Others 
    • End User Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Pharmaceutical Companies
      • Biopharmaceutical Companies
    • Country Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Germany
      • UK
      • France
      • Spain
      • Italy
      • Russia
      • Poland
      • Rest of Europe
    • Europe Peptide API CMO Market – Opportunity Analysis Index, By Product Type, Therapeutic Area, End User, and Country, 2019 – 2025
    • Europe Peptide API CMO Market Dynamics – Trends
  4. Asia-Pacific Peptide API CMO Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
    • By Product Type Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Peptide Generic API
      • Peptide NCEs
    • Therapeutic Area Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Oncology
      • Cardiovascular Disorders
      • metabolic Disorders
      • CNS Disorders
      • Respiratory Disorders
      • Gastrointestinal Disorders
      • Anti-infectives
      • Dermatology
      • Renal Disorders
      • Others 
    • End User Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Pharmaceutical Companies
      • Biopharmaceutical Companies
    • Country Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Japan
      • China
      • India
      • ASEAN
      • Australia & New Zealand
      • Rest of Asia-Pacific
    • Asia-Pacific Peptide API CMO Market – Opportunity Analysis Index, By Product Type, Therapeutic Area, End User, and Country, 2019 – 2025
    • Asia-Pacific Peptide API CMO Market Dynamics – Trends
  5. Latin America Peptide API CMO Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
    • By Product Type Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Peptide Generic API
      • Peptide NCEs
    • Therapeutic Area Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Oncology
      • Cardiovascular Disorders
      • metabolic Disorders
      • CNS Disorders
      • Respiratory Disorders
      • Gastrointestinal Disorders
      • Anti-infectives
      • Dermatology
      • Renal Disorders
      • Others 
    • End User Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Pharmaceutical Companies
      • Biopharmaceutical Companies
    • Country Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Brazil
      • Mexico
      • Argentina
      • Venezuela
      • Rest of Latin America
    • Latin America Peptide API CMO Market – Opportunity Analysis Index, By Product Type, Therapeutic Area, End User, and Country, 2019 – 2025
    • Latin America Peptide API CMO Market Dynamics – Trends
  6. Middle East and Africa Peptide API CMO Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
    • By Product Type Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Peptide Generic API
      • Peptide NCEs
    • Therapeutic Area Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Oncology
      • Cardiovascular Disorders
      • metabolic Disorders
      • CNS Disorders
      • Respiratory Disorders
      • Gastrointestinal Disorders
      • Anti-infectives
      • Dermatology
      • Renal Disorders
      • Others 
    • End User Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Pharmaceutical Companies
      • Biopharmaceutical Companies
    • Country Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Gulf Cooperation Council (GCC) Countries
      • Israel
      • South Africa
      • Rest of MEA
    • MEA Peptide API CMO Market – Opportunity Analysis Index, By Product Type, Therapeutic Area, End User, and Country, 2019 – 2025
    • MEA Peptide API CMO Market Dynamics – Trends
  7. Competition Landscape
    • Strategic Dashboard of Top Market Players
    • Company Profiles (Introduction, Financial Analysis, Therapeutic Area & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
      • ScinoPharm Taiwan, Ltd. (Taiwan)
      • Corden Pharma International (Germany)
      • Bachem AG (Switzerland)
      • Biopeptek Pharmaceuticals LLC. (U.S.)
      • Hybio Pharmaceutical Co., Ltd. (China)
      • Chinese Peptide Company (China)
      • AmbioPharm, Inc. (U.S.)
      • Teva Pharmaceutical Industries Ltd. (Israel)
      • PolyPeptide Group (Sweden)
      • Chemi S.p.A. (Italy)
  1. Research Methodology

Key Assumptions and Acronyms